Cardiovascular Effects of a Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis

被引：2
作者：
Troels M. Busk
Søren Møller
Flemming Bendtsen
机构：
[1] Gastro Unit, Medical Division, Copenhagen University Hospital Hvidovre, Copenhagen
[2] Centre of Functional Imaging and Research, Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Hvidovre, Kettegaard Alle 30, Hvidovre, Copenhagen
来源：
Current Hepatology Reports | 2017年 / 16卷 / 3期
关键词：
Chronic liver disease; Cirrhosis; Cirrhotic cardiomyopathy; Portal hypertension; TIPS;
D O I：
10.1007/s11901-017-0362-x
中图分类号：
学科分类号：
摘要：
Purpose of Review: Insertion of a transjugular intrahepatic portosystemic shunt (TIPS) has proven effective in alleviating complications to portal hypertension such as refractory ascites and variceal bleeding in patients with cirrhosis. Moreover, it increases survival in selected patient groups. However, TIPS also causes marked circulatory changes and a central concern has been whether this could negatively affect cardiac function. Therefore, this review aims to critically discuss our knowledge on cardiovascular effects of a TIPS in cirrhosis. Recent Findings: These suggest that TIPS does not worsen cardiac function. Careful cardiac evaluation prior to TIPS is, however, a prerequisite in order to prevent cardiac complications after TIPS insertion. Summary: The focus on cirrhotic cardiomyopathy has raised the awareness on specific procedures such as TIPS. Thus, previous studies have demonstrated that TIPS seemingly worsens cardiac function with a negative effect on ascites clearance and survival. However, recent studies have not been able to establish this deleterious interplay and the overall frequency of cardiac failure after TIPS still remains low. Hence, TIPS seems to be safe with regard to cardiac function in patients with cirrhosis. © Springer Science+Business Media, LLC 2017.
引用
收藏
页码：250 / 257
页数：7
相关论文
共 69 条
[1]  
Rossle M., Gerbes A.L., TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update, Gut, 59, 7, pp. 988-1000, (2010)
[2]  
Sauerbruch T., Mengel M., Dollinger M., Zipprich A., Rossle M., Panther E., Et al., Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy, Gastroenterology, 149, 3, pp. 660-668, (2015)
[3]  
Garcia-Pagan J.C., Caca K., Bureau C., Laleman W., Appenrodt B., Luca A., Et al., Early use of TIPS in patients with cirrhosis and variceal bleeding, N Engl J Med, 362, 25, pp. 2370-2379, (2010)
[4]  
Bureau C., Thabut D., Oberti F., Dharancy S., Carbonell N., Bouvier A., Et al., Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites, Gastroenterology, 152, 1, pp. 157-163, (2017)
[5]  
Salerno F., Camma C., Enea M., Rossle M., Wong F., Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data, Gastroenterology, 133, 3, pp. 825-834, (2007)
[6]  
Wong W., Liu P., Blendis L., Wong F., Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites, Am J Med, 106, 3, pp. 315-322, (1999)
[7]  
Wong F., Sniderman K., Liu P., Blendis L., The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt, Gastroenterology, 112, 3, pp. 899-907, (1997)
[8]  
Gerbes A.L., Gulberg V., Waggershauser T., Holl J., Reiser M., Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites, Hepatology, 28, 3, pp. 683-688, (1998)
[9]  
Salerno F., Cazzaniga M., Pagnozzi G., Cirello I., Nicolini A., Meregaglia D., Et al., Humoral and cardiac effects of TIPS in cirrhotic patients with different “effective” blood volume, Hepatology, 38, 6, pp. 1370-1377, (2003)
[10]  
Moller S., Henriksen J.H., Cirrhotic cardiomyopathy, J Hepatol, 53, 1, pp. 179-190, (2010)
1234567